Dow Up1.31% Nasdaq Up2.40%

Codexis, Inc. (CDXS)

-NasdaqGS
2.30 Up 0.01(0.44%) 4:00PM EDT
CompetitorsGet Competitors for:
Direct Competitor Comparison 
CDXSPVT1PVT2PVT3Industry
Market Cap:90.00MN/AN/AN/A142.24M
Employees:1259,93516,236124,349159.00
Qtrly Rev Growth (yoy):-0.06N/AN/AN/A0.18
Revenue (ttm): 27.11M4.02B12.17B112.46B110.77M
Gross Margin (ttm):-0.29N/AN/AN/A0.51
EBITDA (ttm):-22.24MN/AN/AN/A-9.72M
Operating Margin (ttm): -1.15N/AN/AN/A-1.48
Net Income (ttm):-33.93M97.70M1405.90M1373.10M1N/A
EPS (ttm):-0.89N/AN/AN/A-0.23
P/E (ttm):N/AN/AN/AN/A27.10
PEG (5 yr expected):-0.52N/AN/AN/A0.05
P/S (ttm):3.31N/AN/AN/A14.99
 
Pvt1 = Lonza Group AG
Pvt2 = Novozymes A/S
Pvt3 = Royal DSM N.V.
Industry = Biotechnology
1 = As of 2013  

Biotechnology Companies Ranked By Sales 
CompanySymbolPriceChangeMarket CapP/E
Amgen Inc.AMGN144.090.05109.45B22.06
Genentech, Inc.Private - View Profile
Biogen Idec Inc.BIIB326.770.0577.16B36.35
Genzyme CorporationPrivate - View Profile
Merck Serono S.A.Private - View Profile
Gilead Sciences Inc.GILD106.670.04161.25B24.17
MedImmune, L.L.C.Private - View Profile
Life Technologies CorporationPrivate - View Profile
Teva Pharmaceutical Industries LimitedTEVA53.260.0345.47B17.54
Sandoz International GmbHPrivate - View Profile
 
View Biotechnology Industry Center

Generic Drugmakers Ranked by Sales 
CompanySymbolPriceChangeMarket CapP/E
Actavis plcACT232.130.0261.34B609.27
Ranbaxy Laboratories LimitedPrivate - View Profile
Mylan, Inc.MYL52.040.0319.47B35.43
Pfizer Inc.PFE28.280.01179.32B17.76
Johnson & JohnsonJNJ100.360.01283.04B16.62
GlaxoSmithKline plcGSK43.630.00104.80B13.99
SanofiSNY52.150.01136.85B26.19
Novartis AGNVS88.610.01214.99B22.50
Roche Holding AGRHHBY36.390.02247.27B22.02
AstraZeneca PLCAZN69.000.0287.15B43.04
 
View Biotechnology Industry Center

Drugmakers Ranked By Sales 
CompanySymbolPriceChangeMarket CapP/E
Abbott LaboratoriesABT42.390.0263.74B27.58
Bristol-Myers Squibb CompanyBMY51.950.0386.13B32.27
 
View Biotechnology Industry Center

 
News on Direct Competitors 
No Direct Competitor Comparision

Currency in USD.